Bausch + Lomb Corp (BLCO) - Net Assets
Based on the latest financial reports, Bausch + Lomb Corp (BLCO) has net assets worth CA$6.50 Billion CAD (≈ $4.70 Billion USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$13.83 Billion ≈ $10.01 Billion USD) and total liabilities (CA$7.33 Billion ≈ $5.30 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check BLCO intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CA$6.50 Billion |
| % of Total Assets | 46.99% |
| Annual Growth Rate | -8.19% |
| 5-Year Change | -34.48% |
| 10-Year Change | N/A |
| Growth Volatility | 8.59 |
Bausch + Lomb Corp - Net Assets Trend (2019–2024)
This chart illustrates how Bausch + Lomb Corp's net assets have evolved over time, based on quarterly financial data. See how many days can Bausch + Lomb Corp fund operations to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Bausch + Lomb Corp (2019–2024)
The table below shows the annual net assets of Bausch + Lomb Corp from 2019 to 2024. For live valuation and market cap data, see Bausch + Lomb Corp (BLCO) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CA$6.54 Billion ≈ $4.73 Billion |
-5.43% |
| 2023-12-31 | CA$6.92 Billion ≈ $5.01 Billion |
-2.55% |
| 2022-12-31 | CA$7.10 Billion ≈ $5.14 Billion |
-24.47% |
| 2021-12-31 | CA$9.40 Billion ≈ $6.80 Billion |
-5.87% |
| 2020-12-31 | CA$9.99 Billion ≈ $7.23 Billion |
-0.44% |
| 2019-12-31 | CA$10.03 Billion ≈ $7.26 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Bausch + Lomb Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 57100000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CA$7.04 Billion | 108.82% |
| Total Equity | CA$6.47 Billion | 100.00% |
Bausch + Lomb Corp Competitors by Market Cap
The table below lists competitors of Bausch + Lomb Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Leo Group Co Ltd
SHE:002131
|
$5.39 Billion |
|
Installed Building Products Inc
NYSE:IBP
|
$5.39 Billion |
|
Gecina SA
PA:GFC
|
$5.40 Billion |
|
Amentum Holdings Inc.
NYSE:AMTM
|
$5.41 Billion |
|
AMMB Holdings Bhd
KLSE:1015
|
$5.39 Billion |
|
West Fraser Timber Co Ltd
TO:WFG
|
$5.39 Billion |
|
Janus Living, Inc.
NYSE:JAN
|
$5.38 Billion |
|
Caitong Securities Co Ltd
SHG:601108
|
$5.38 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Bausch + Lomb Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 6,850,000,000 to 6,473,000,000, a change of -377,000,000 (-5.5%).
- Net loss of 317,000,000 reduced equity.
- Other comprehensive income increased equity by 1,245,000,000.
- Other factors decreased equity by 1,305,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CA$-317.00 Million | -4.9% |
| Other Comprehensive Income | CA$1.25 Billion | +19.23% |
| Other Changes | CA$-1.30 Billion | -20.16% |
| Total Change | CA$- | -5.50% |
Book Value vs Market Value Analysis
This analysis compares Bausch + Lomb Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.14x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.74x to 1.14x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | CA$28.45 | CA$21.03 | x |
| 2020-12-31 | CA$28.34 | CA$21.03 | x |
| 2021-12-31 | CA$26.65 | CA$21.03 | x |
| 2022-12-31 | CA$20.08 | CA$21.03 | x |
| 2023-12-31 | CA$19.54 | CA$21.03 | x |
| 2024-12-31 | CA$18.37 | CA$21.03 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Bausch + Lomb Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -4.90%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -6.62%
- • Asset Turnover: 0.36x
- • Equity Multiplier: 2.08x
- Recent ROE (-4.90%) is below the historical average (-0.62%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 2.99% | 7.89% | 0.33x | 1.15x | CA$-697.90 Million |
| 2020 | -0.17% | -0.50% | 0.30x | 1.14x | CA$-1.01 Billion |
| 2021 | 1.95% | 4.83% | 0.35x | 1.16x | CA$-750.90 Million |
| 2022 | 0.21% | 0.40% | 0.34x | 1.58x | CA$-688.30 Million |
| 2023 | -3.80% | -6.27% | 0.31x | 1.96x | CA$-945.00 Million |
| 2024 | -4.90% | -6.62% | 0.36x | 2.08x | CA$-964.30 Million |
Industry Comparison
This section compares Bausch + Lomb Corp's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $8,245,849
- Average return on equity (ROE) among peers: -13.82%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Bausch + Lomb Corp (BLCO) | CA$6.50 Billion | 2.99% | 1.13x | $5.39 Billion |
| Covalon Technologies Ltd. (COV) | $8.27 Million | -26.68% | 0.06x | $44.15 Million |
| Ocumetics Technology Corp (OTC) | $-3.94 Million | 0.00% | 0.00x | $50.80 Million |
| ZEN Graphene Solutions Ltd (ZEN) | $20.42 Million | -14.77% | 0.01x | $46.46 Million |
About Bausch + Lomb Corp
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily d… Read more